New Potassium Binders for the Treatment of Hyperkalemia-Reference-Cited by-同舟云学术

New Potassium Binders for the Treatment of Hyperkalemia

Published:2015-10 Issue:4 Volume:66 Page:731-738
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Pitt Bertram¹,Bakris George L.¹

Affiliation:

1. From the Department of Medicine, University of Michigan School of Medicine, Ann Arbor (B.P.); and ASH Comprehensive Hypertension Center, Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, The University of Chicago Medicine, IL (G.L.B.)

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference38 articles.

1. Managing Hyperkalemia Caused by Inhibitors of the Renin–Angiotensin–Aldosterone System

2. A Physiologic-Based Approach to the Evaluation of a Patient With Hyperkalemia

3. The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease

4. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.;Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group;Kidney inter, Suppl,2013

5. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperkalemia in chronic kidney disease patients with and without heart failure: an Italian economic modelling study;Cost Effectiveness and Resource Allocation;2024-05-21

2. Hypertension and Chronic Kidney Disease Including Dialysis;Hypertension;2024

3. Potassium‐lowering effects of sodium zirconium cyclosilicate in the early post‐transplant period;Clinical Transplantation;2023-10-09

4. Early diagnosis of chronic kidney disease in patients with diabetes in France: multidisciplinary expert opinion, prevention value and practical recommendations;Postgraduate Medicine;2023-09-21

5. Hyperkalemia in chronic kidney disease: a focus on potassium lowering pharmacotherapy;Expert Opinion on Pharmacotherapy;2023-08-13